Acquiring a Diagnostic Lab — Need Referrals & Transition Insights
October 23, 2025
by an investor from California State University, Long Beach in San Diego, CA, USA
I’m in the process of acquiring a CLIA-certified molecular diagnostics lab in California and would appreciate advice from anyone who has gone through a similar acquisition.
I’m looking for referrals to a healthcare transaction attorney and CPA with experience in:
– Diagnostic / CLIA lab deals
– SBA + seller-financing structures
– Regulatory continuity (CLIA/CDPH) and payer contracts
Also curious what red flags to watch for in post-COVID lab transitions — things like payer audit risk, reimbursement trends, staffing/licensing issues, or compliance pitfalls.
Any referrals or lessons learned would be appreciated.
from Cornell University in Los Angeles, CA, USA
from Eastern Illinois University in 900 E Diehl Rd, Naperville, IL 60563, USA